Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

ORAMED PHARMACEUTICALS INC (ORMP)

53 + Investors. Track Smart Money conviction in ORMP. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +8
Streak
1Q ▲
Buyers last Q
62%

Smart Money Signals — ORMP

Based on 53 hedge funds · latest filing: 2025 Q4 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds added ORMP than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (96% of max)

96% of all-time peak
53 hedge funds hold ORMP right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📉

Outflows — 4% fewer funds vs a year ago

fund count last 6Q
2 fewer hedge funds hold ORMP compared to a year ago (-4% decline). When institutions consistently reduce their exposure, it's worth exploring the underlying fundamental reasons driving them away.
🟢

More buyers than sellers — 62% buying

25 buying15 selling
Last quarter: 25 funds were net buyers (13 opened a brand new position + 12 added to an existing one). Only 15 were sellers (10 trimmed + 5 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+9 vs last Q)

new funds entering per quarter
Funds opening a new ORMP position: 4 → 4 → 4 → 13. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

66% of holders stayed for 2+ years

66% conviction (2yr+) 21% medium 13% new
35 out of 53 hedge funds have held ORMP for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares +26%, value -100%

Value
-99%
Shares
+25%
Last quarter: funds added +26% more shares while total portfolio value only changed -100%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
📈

Growing discovery — still being found

9 → 4 → 4 → 4 → 13 new funds/Q
New funds entering each quarter: 4 → 4 → 4 → 13. A growing number of institutions are discovering ORMP each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Deep conviction — 74% of holders stayed 2+ years

74% veterans 11% 1-2yr 15% new
Of 53 current holders: 39 (74%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
📋

Smaller funds dominant — 7% AUM from top-100

7% from top-100 AUM funds
14 of 53 holders rank in the top 100 by AUM, but together hold only 7% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
3.1
out of 10
Low Exit Risk
Exit risk score 3.1/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — ORMP

In 2025 Q4, 25 hedge funds were net buyers of ORMP (13 opened a new position, 12 added to an existing one), while 15 reduced or exited (10 trimmed, 5 sold completely) — a 62% buyer ratio, indicating clear institutional accumulation. Net fund flow last quarter: +8 funds (more new holders than closures). Total institutional holders: 53.

Hedge Fund Ownership: ORMP

How many hedge funds hold ORMP — quarterly history vs. share price
Quarterly hedge fund ownership of ORMP vs. share price

Market Analysis: ORMP

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: ORMP

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

7 top-rated funds 1 high-conviction
Consensus
3.9
/ 10
breadth
×
Elite
1.7
/ 10
conviction
Hedge Fund Positioning: ORMP
2026 Q1 Stats Unlock in 5 days 53 + Investors

Track Smart Money conviction in ORMP. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2025 Q4) Prior (2025 Q3) Change
Funds Holding 53 45 17.78%
13F Shares 9M 7M 25.52%
Total Value $26M $8.37B -99.69%
New Positions 13 4 +9
Increased Positions 12 11 +1
Closed Positions 5 5 -
Reduced Positions 10 10 -
Total Calls 0 0 -
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: ORMP

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

53 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ORMP. Verified SEC 13F-HR filings.

QUARTER:
Top 25 institutional holders of ORMP — 2025 Q4 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 BML Capital Management, LLC 6.91% 3,167,231 $10.8M
2 Gem Investment Advisors, LLC 5.48% 1,640,069 $5.6M
3 Aquamarine Financial (Cayman) Ltd 0.53% 2,112,312 $7.2M
4 Redwood Family Wealth LLC 0.07% 22,065 $75K
5 Sage Capital Management, LLC 0.03% 17,977 $61K
6 BOOTHBAY FUND MANAGEMENT, LLC 0.03% 600,716 $2.0M
7 Catalyst Funds Management Pty Ltd 0.01% 23,500 $80K
8 Glass Jacobson Investment Advisors llc 0.01% 10,540 $36K
9 PRELUDE CAPITAL MANAGEMENT, LLC 0.01% 35,313 $120K
10 RITHOLTZ WEALTH MANAGEMENT 0.01% 155,479 $529K
11 Hillsdale Investment Management Inc. 0.01% 97,300 $331K
12 Pioneer Family Office, LLC 0.01% 3,000 $10K
13 AXQ CAPITAL, LP 0.00% 11,326 $39K
14 Rathbones Group PLC 0.00% 233,018 $792K
15 Kathmere Capital Management, LLC 0.00% 15,071 $51K
16 BAILARD, INC. 0.00% 32,478 $110K
17 O'SHAUGHNESSY ASSET MANAGEMENT, LLC 0.00% 116,363 $396K
18 XTX Topco Ltd 0.00% 22,688 $77K
19 TrinityBridge Ltd 0.00% 11,675
20 ALGERT GLOBAL LLC 0.00% 19,218
21 MARSHALL WACE, LLP 0.00% 259,611 $883K
22 N.E.W. Advisory Services LLC 0.00% 3,429 $12K
23 RENAISSANCE TECHNOLOGIES LLC 0.00% 147,700 $502K
24 Hudson Bay Capital Management LP 0.00% 51,670 $176K
25 Connor, Clark & Lunn Investment Management Ltd. 0.00% 50,207 $171K
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — ORAMED PHARMACEUTICALS INC (ORMP)

What does the Smart Money Trend signal show for ORMP?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added ORMP than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for ORMP?

More buyers than sellers — 62% buying: Last quarter: 25 funds were net buyers (13 opened a brand new position + 12 added to an existing one). Only 15 were sellers (10 trimmed + 5 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for ORMP holders?

Smaller funds dominant — 7% AUM from top-100: 14 of 53 holders rank in the top 100 by AUM, but together hold only 7% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held ORMP?

66% of holders stayed for 2+ years: 35 out of 53 hedge funds have held ORMP for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.